CRISPR Therapeutics AG
ANTI-IDIOTYPE ANTIBODIES TARGETING ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR
Last updated:
Abstract:
High affinity antibodies capable of binding to a single-chain variable fragment (scFv) of anti-BCMA antibody, for example, the scFv expressed on cell surface as a portion of a chimeric antigen receptor (CAR). Also provided herein are methods for producing such anti-scFv antibodies and methods of using the antibodies disclosed herein for detecting, for example, T cells expressing an anti-BCMA CAR that comprise the scFv as an extracellular domain.
Status:
Application
Type:
Utility
Filling date:
23 Aug 2021
Issue date:
3 Mar 2022